What are lipoproteins doing in the brainα

Trends in Endocrinology and Metabolism

Volumn 25, Issue 1, 2014, Pages 8-14

  Wang, Hong ^a   Eckel, Robert H ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocyte; Brain; Lipoprotein; Lipoprotein receptor; Metabolism; Neuron

Indexed keywords

APOLIPOPROTEIN E; CLUSTERIN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LIPOPROTEIN LIPASE; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; LRP1 RECEPTOR; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ASTROCYTE; BRAIN; CELL TYPE; CENTRAL NERVOUS SYSTEM; HIPPOCAMPUS; LIPID RAFT; LIPOPROTEIN METABOLISM; LIPOPROTEIN SYNTHESIS; NEURONAL POROSOME; PLASMA; PRIORITY JOURNAL; REVIEW; SYSTEMIC CIRCULATION;

ASTROCYTE; BRAIN; LIPOPROTEIN; LIPOPROTEIN RECEPTOR; METABOLISM; NEURON;

ANIMALS; ANTIGENS, CD36; APOLIPOPROTEINS E; BLOOD-BRAIN BARRIER; BRAIN; HUMANS; LIPOPROTEIN LIPASE; LIPOPROTEINS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; MEMBRANE MICRODOMAINS; MICE; NEURONS; RECEPTORS, LDL;

EID: 84890987858     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2013.10.003     Document Type: Review

References (68)

1. Vickers K.C., Remaley A.T. Lipid-based carriers of microRNAs and intercellular communication. Curr. Opin. Lipidol. 2012, 23:91-97.
2. Ladu M.J., et al. Lipoproteins in the central nervous system. Ann. N. Y. Acad. Sci. 2000, 903:167-175.
3. Neely M.D., Montine T.J. CSF lipoproteins and Alzheimer's disease. J. Nutr. Health Aging 2002, 6:383-391.
4. Koch S., et al. Characterization of four lipoprotein classes in human cerebrospinal fluid. J. Lipid Res. 2001, 42:1143-1151.
5. Felgenhauer K., et al. Evaluation of the blood-CSF barrier by protein gradients and the humoral immune response within the central nervous system. J. Neurol. Sci. 1976, 30:113-128.
6. Rapoport S.I., Pettigrew K.D. A heterogenous, pore-vesicle membrane model for protein transfer from blood to cerebrospinal fluid at the choroid plexus. Microvasc. Res. 1979, 18:105-119.
7. Liu M., et al. Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice. Am. J. Physiol Regul. Integr. Comp Physiol 2012, 303:R903-R908.
8. Vance J.E., Hayashi H. Formation and function of apolipoprotein E-containing lipoproteins in the nervous system. Biochim. Biophys. Acta 2010, 1801:806-818.
9. Quan G., et al. Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. Brain Res. Dev. Brain Res. 2003, 146:87-98.
10. Pfrieger F.W., Ungerer N. Cholesterol metabolism in neurons and astrocytes. Prog. Lipid Res. 2011, 50:357-371.
11. Chen J., et al. Cholesterol efflux is differentially regulated in neurons and astrocytes: implications for brain cholesterol homeostasis. Biochim. Biophys. Acta 2013, 1831:263-275.
12. Elliott D.A., et al. Apolipoproteins in the brain: implications for neurological and psychiatric disorders. Clin. Lipidol. 2010, 51:555-573.
13. Calero M., et al. Apolipoprotein J (clusterin) and Alzheimer's disease. Microsc. Res. Tech. 2000, 50:305-315.
14. DeMattos R.B., et al. Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice. Neurochem. Int. 2001, 39:415-425.
15. Hayashi H., et al. Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1. J. Neurosci. 2007, 27:1933-1941.
16. Holtzman D.M., et al. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2012, 2:a006312.
17. Martiskainen H., et al. Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease. Expert Opin. Ther. Targets 2013, 17:781-794.
18. Verghese P.B., et al. ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:E1807-E1816.
19. Ladu M.J., et al. Preferential interactions between ApoE-containing lipoproteins and Abeta revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift. Biochim. Biophys. Acta 2012, 1821:295-302.
20. Evola M., et al. Oxidative stress impairs learning and memory in apoE knockout mice. Pharmacol. Biochem. Behav. 2010, 96:181-186.
21. Xu Y., et al. A common Hpa I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E. J. Lipid Res. 1999, 40:50-58.
22. Abildayeva K., et al. Human apolipoprotein C-I expression in mice impairs learning and memory functions. J. Lipid Res. 2008, 49:856-869.
23. Berbee J.F., et al. Apolipoprotein CI knock-out mice display impaired memory functions. J. Alzheimers Dis. 2011, 23:737-747.
24. Sebastiao A.M., et al. Lipid rafts, synaptic transmission and plasticity: impact in age-related neurodegenerative diseases. Neuropharmacology 2013, 64:97-107.
25. Lemaire-Ewing S., et al. Lipid rafts: a signalling platform linking lipoprotein metabolism to atherogenesis. Atherosclerosis 2012, 221:303-310.
26. Marin R., et al. Lipid raft disarrangement as a result of neuropathological progresses: A novel strategy for early diagnosisα. Neuroscience 2013, 245:26-39.
27. Sorci-Thomas M.G., et al. Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers. J. Lipid Res. 2012, 53:1890-1909.
28. Lee J.S., et al. Neuronal porosome proteome: molecular dynamics and architecture. J. Proteomics 2012, 75:3952-3962.
29. Cho W.J., et al. Conformation states of the neuronal porosome complex. Cell Biol. Int. 2010, 34:1129-1132.
30. Cho W.J., et al. EM 3D contour maps provide protein assembly at the nanoscale within the neuronal porosome complex. J. Microsc. 2008, 232:106-111.
31. Cho W.J., et al. Structure, isolation, composition and reconstitution of the neuronal fusion pore. Cell Biol. Int. 2004, 28:699-708.
32. Jeremic A., et al. Cholesterol is critical to the integrity of neuronal porosome/fusion pore. Ultramicroscopy 2006, 106:674-677.
33. Cho W.J., et al. Neuronal fusion pore assembly requires membrane cholesterol. Cell Biol. Int. 2007, 31:1301-1308.
34. Lee J.S., et al. Porosome in astrocytes. J. Cell. Mol. Med. 2009, 13:365-372.
35. Cho W.J., et al. Nanoscale 3D contour map of protein assembly within the astrocyte porosome complex. Cell Biol. Int. 2009, 33:224-229.
36. Goti D., et al. Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL-associated vitamin E. J. Neurochem. 2001, 76:498-508.
37. Mardones P., et al. Alpha-tocopherol metabolism is abnormal in scavenger receptor class B type I (SR-BI)-deficient mice. J. Nutr. 2002, 132:443-449.
38. Balazs Z., et al. Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model. J. Neurochem. 2004, 89:939-950.
39. Panzenboeck U., et al. ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells. J. Biol. Chem. 2002, 277:42781-42789.
40. Sovic A., et al. Scavenger receptor class B, type I mediates uptake of lipoprotein-associated phosphatidylcholine by primary porcine cerebrovascular endothelial cells. Neurosci. Lett. 2004, 368:11-14.
41. Elder G.A., et al. Increased locomotor activity in mice lacking the low-density lipoprotein receptor. Behav. Brain Res. 2008, 191:256-265.
42. de O.J., et al. Positive correlation between elevated plasma cholesterol levels and cognitive impairments in LDL receptor knockout mice: relevance of cortico-cerebral mitochondrial dysfunction and oxidative stress. Neuroscience 2011, 197:99-106.
43. -/-): evidence of antioxidant imbalance and increased acetylcholinesterase activity in the prefrontal cortex. J. Alzheimers Dis. 2012, 32:495-511.
44. Ali B.R., et al. A missense founder mutation in VLDLR is associated with dysequilibrium syndrome without quadrupedal locomotion. BMC Med. Genet. 2012, 13:80.
45. Moheb L.A., et al. Identification of a nonsense mutation in the very low-density lipoprotein receptor gene (VLDLR) in an Iranian family with dysequilibrium syndrome. Eur. J. Hum. Genet. 2008, 16:270-273.
46. Boycott K.M., et al. Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification. Am. J. Hum. Genet. 2005, 77:477-483.
47. Ozcelik T., et al. Mutations in the very low-density lipoprotein receptor VLDLR cause cerebellar hypoplasia and quadrupedal locomotion in humans. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:4232-4236.
48. Trommsdorff M., et al. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 1999, 97:689-701.
49. Weeber E.J., et al. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J. Biol. Chem. 2002, 277:39944-39952.
50. Dumanis S.B., et al. ApoE receptor 2 regulates synapse and dendritic spine formation. PLoS ONE 2011, 6:e17203.
51. Rahman T., et al. The very low density lipoprotein receptor is not necessary for maintaining brain polyunsaturated fatty acid concentrations. Prostaglandins Leukot. Essent. Fatty Acids 2010, 82:141-145.
52. Purdon D., et al. No evidence for direct incorporation of esterified palmitic acid from plasma into brain lipids of awake adult rat. J. Lipid Res. 1997, 38:526-530.
53. Beffert U., et al. Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2. Neuron 2005, 47:567-579.
54. Fernandez-Castaneda A., et al. Identification of the low density lipoprotein (LDL) receptor-related protein-1 interactome in central nervous system myelin suggests a role in the clearance of necrotic cell debris. J. Biol. Chem. 2013, 288:4538-4548.
55. Matsuo M., et al. Involvement of low-density lipoprotein receptor-related protein and ABCG1 in stimulation of axonal extension by apoE-containing lipoproteins. Biochim. Biophys. Acta 2011, 1811:31-38.
56. Lillis A.P., et al. LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol. Rev. 2008, 88:887-918.
57. Liu Q., et al. Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron 2007, 56:66-78.
58. Liu Q., et al. Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration. J. Neurosci. 2010, 30:17068-17078.
59. Huang Y. Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models. Biochem. Soc. Trans. 2011, 39:924-932.
60. Buttini M., et al. Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice. Am. J. Pathol. 2010, 177:563-569.
61. Jain S., et al. Cellular source-specific effects of apolipoprotein (apo) E4 on dendrite arborization and dendritic spine development. PLoS ONE 2013, 8:e59478.
62. Rolyan H., et al. Amyloid-beta protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease. J. Neural Transm. 2011, 118:699-712.
63. Liu Q., et al. Lipoprotein receptor LRP1 regulates leptin signaling and energy homeostasis in the adult central nervous system. PLoS Biol. 2011, 9:e1000575.
64. May P., et al. Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice. Mol. Cell. Biol. 2004, 24:8872-8883.
65. Wang H., et al. Deficiency of lipoprotein lipase in neurons modifies the regulation of energy balance and leads to obesity. Cell Metab. 2011, 13:105-113.
66. Wang H., Eckel R.H. Lipoprotein lipase: from gene to obesity. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E271-E288.
67. Wang H., Eckel R.H. Lipoprotein lipase in the brain and nervous system. Annu. Rev. Nutr. 2012, 32:147-160.
68. Xian X., et al. Presynaptic defects underlying impaired learning and memory function in lipoprotein lipase-deficient mice. J. Neurosci. 2009, 29:4681-4685.